Innovations in
chromatography, cell culture and viral vectors

Innovations in cell culture

Developing the future

Register | 19 November, 2020 | 2:00 PM EST


Developing an upstream cell culture process is hard work. We know that you and your team can spend upwards of ten hours a day in the lab setting up and testing a hypothesis. The aim of this event is to provide you with a basis to decide whether or not a particular innovation is right for your company, prior to you and your team spending countless hours in the lab. We’ll do this by providing a forum where leaders will debate the costs versus benefits of selecting certain cell culture process development innovations.

Discussion topics:
Animal derived vs ADCF (animal derived component free), adherent vs suspension cells, custom media vs off-the-shelf, benefits of new non-mammalian platforms

Who should attend:
  • Gene therapy researchers
  • Research scientists cell culture
  • Principal Scientists cell culture
  • Upstream process development engineers, scientists, and managers
  • MSAT upstream engineers, scientists, and managers
Register now

Innovations in cell culture

Manufacturing of the future

Register | December 3, 2020 | 2:00 PM EST


What does the future of upstream manufacturing look like? Join the discussion to find out how you can innovate with raw material characterization, electronic batch records, infrastructure, second sourcing, and media finger printing. Hear the different perspectives on these topics from industry leaders. Is your organization ready to consider these innovations and take a leap into the future of upstream manufacturing?

Discussion topics:
Raw material characterization, electronic batch records, single-use vs stainless vs hybrid, importance of second sourcing, and media fingerprinting

Who should attend:
  • Bioprocess manufacturing engineers
  • Manufacturing scientist
  • MSAT upstream engineers
  • Manufacturing managers
Register now

Innovations in viral vectors

Development to manufacturing

Register | 17 December, 2020 | 2:00 PM EST


As part of our new Innovations series, Cytiva will be hosting a FREE open discussion on viral vectors. Get answers to your questions and discuss the latest trends and best practices with industry scientists and experts from Cytiva.

Discussion topics:
Titer vs scale, in-house vs outsourcing, resin vs fiber for virus purification

Who should attend:
  • Gene therapy researchers
  • Viral vector developers
  • Upstream process development engineers and scientists
  • Bioprocess manufacturing engineers
Register now

Coming in 2021

Innovations in chromatography
February 2021
Innovations in connected processing
March 2021